Evaluation of HER2 gene amplification in breast cancer using nuclei microarray in situ hybridization.

about

Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell.Comparison of immunohistochemistry and mRNA in situ hybridization in detecting thyroid transcription factor-1 expression in non-small cell lung carcinomas tissue.

P2860

Q33751048-7AA773A8-F65C-4504-91AE-4554F9EA2189 Q36334237-FB5E3D38-62CE-4A42-AAB4-456B2301000C

P2860

Evaluation of HER2 gene amplification in breast cancer using nuclei microarray in situ hybridization.

Item

http://www.wikidata.org/entity/Q36057270

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Evaluation of HER2 gene amplif ...... roarray in situ hybridization.

@ast

Evaluation of HER2 gene amplif ...... roarray in situ hybridization.

@en

type

Item

label

Evaluation of HER2 gene amplif ...... roarray in situ hybridization.

@ast

Evaluation of HER2 gene amplif ...... roarray in situ hybridization.

@en

prefLabel

Evaluation of HER2 gene amplif ...... roarray in situ hybridization.

@ast

Evaluation of HER2 gene amplif ...... roarray in situ hybridization.

@en

P1476

Evaluation of HER2 gene amplif ...... roarray in situ hybridization.

@en

P2093

Cheng Zhang

http://www.w3.org/2001/XMLSchema#string

Huiyong Jiang

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Bai

http://www.w3.org/2001/XMLSchema#string

Xuefeng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The important molecular markers on chromosome 17 and their clinical impact in breast cancer

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Agarose mold embedding of cultured cells for tissue microarrays.

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Amplification of tissue by construction of tissue microarrays.

Epigenetic therapy for breast cancer.

Tissue microarrays: bridging the gap between research and the clinic.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

P304

5519-5527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS13055519

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228106089

http://www.w3.org/2001/XMLSchema#string

P698

22754312

http://www.w3.org/2001/XMLSchema#string

P932

3382781

http://www.w3.org/2001/XMLSchema#string

Evaluation of HER2 gene amplification in breast cancer using nuclei microarray in situ hybridization.

about

P2860

P2860

Evaluation of HER2 gene amplification in breast cancer using nuclei microarray in situ hybridization.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932